$1.67 Billion is the total value of BRIDGER MANAGEMENT, LLC's 34 reported holdings in Q3 2017. The portfolio turnover from Q2 2017 to Q3 2017 was 24.3% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
MDCO | Buy | MEDICINES CO | $104,044,000 | +11.2% | 2,808,954 | +14.1% | 6.23% | +16.7% |
POST | Sell | POST HLDGS INC | $102,377,000 | +12.5% | 1,159,818 | -1.1% | 6.13% | +18.0% |
GDDY | GODADDY INCcl a | $88,612,000 | +2.6% | 2,036,589 | 0.0% | 5.31% | +7.6% | |
ALXN | Buy | ALEXION PHARMACEUTICALS INC | $77,878,000 | +210.7% | 555,120 | +169.5% | 4.66% | +226.1% |
ERI | ELDORADO RESORTS INC | $69,130,000 | +28.2% | 2,695,132 | 0.0% | 4.14% | +34.6% | |
TPX | Sell | TEMPUR SEALY INTL INC | $67,381,000 | +2.1% | 1,044,337 | -15.5% | 4.04% | +7.2% |
WMGI | Buy | WRIGHT MED GROUP N V | $66,095,000 | +25.5% | 2,554,894 | +33.4% | 3.96% | +31.8% |
AWI | ARMSTRONG WORLD INDS INC NEW | $64,137,000 | +11.4% | 1,251,456 | 0.0% | 3.84% | +16.9% | |
TGTX | Buy | TG THERAPEUTICS INC | $62,746,000 | +34.4% | 5,295,044 | +14.0% | 3.76% | +41.0% |
XBI | New | SPDR SERIES TRUSTput | $62,417,000 | – | 721,000 | +100.0% | 3.74% | – |
AET | Buy | AETNA INC NEW | $61,394,000 | +17.4% | 386,100 | +12.1% | 3.68% | +23.2% |
AGN | Buy | ALLERGAN PLC | $58,616,000 | +8.2% | 286,002 | +28.3% | 3.51% | +13.5% |
MS | MORGAN STANLEY | $58,303,000 | +8.1% | 1,210,359 | 0.0% | 3.49% | +13.4% | |
NKTR | Sell | NEKTAR THERAPEUTICS | $54,592,000 | -0.7% | 2,274,661 | -19.1% | 3.27% | +4.2% |
HUM | Buy | HUMANA INC | $54,205,000 | +5.1% | 222,490 | +3.8% | 3.25% | +10.3% |
ZBH | Buy | ZIMMER BIOMET HLDGS INC | $50,807,000 | -1.9% | 433,917 | +7.6% | 3.04% | +3.0% |
MRK | Sell | MERCK & CO INC | $50,423,000 | -0.7% | 787,497 | -0.6% | 3.02% | +4.2% |
MGM | Buy | MGM RESORTS INTERNATIONAL | $49,645,000 | +52.9% | 1,523,332 | +46.8% | 2.97% | +60.4% |
EVHC | Sell | ENVISION HEALTHCARE CORP | $49,184,000 | -41.3% | 1,094,194 | -18.1% | 2.94% | -38.4% |
ALNY | Sell | ALNYLAM PHARMACEUTICALS INC | $45,108,000 | -25.5% | 383,933 | -49.4% | 2.70% | -21.8% |
CHTR | Sell | CHARTER COMMUNICATIONS INC Ncl a | $42,196,000 | -9.3% | 116,109 | -15.9% | 2.53% | -4.8% |
IRWD | Buy | IRONWOOD PHARMACEUTICALS INC | $40,152,000 | +87.3% | 2,546,095 | +124.3% | 2.40% | +96.6% |
FB | Sell | FACEBOOK INCcl a | $38,673,000 | -20.3% | 226,328 | -29.6% | 2.32% | -16.4% |
INCY | Sell | INCYTE CORP | $36,804,000 | -20.6% | 315,262 | -14.3% | 2.20% | -16.6% |
LBRDA | LIBERTY BROADBAND CORP | $36,758,000 | +9.8% | 390,292 | 0.0% | 2.20% | +15.2% | |
VRSN | Sell | VERISIGN INC | $33,725,000 | -8.6% | 316,997 | -20.2% | 2.02% | -4.1% |
MOH | Buy | MOLINA HEALTHCARE INC | $28,422,000 | +1.3% | 413,347 | +1.9% | 1.70% | +6.3% |
ATRA | Buy | ATARA BIOTHERAPEUTICS INC | $27,349,000 | +28.2% | 1,652,513 | +8.4% | 1.64% | +34.5% |
COG | New | CABOT OIL & GAS CORP | $24,586,000 | – | 919,090 | +100.0% | 1.47% | – |
CMG | Buy | CHIPOTLE MEXICAN GRILL INC | $17,151,000 | +21.0% | 55,716 | +63.6% | 1.03% | +26.9% |
PVG | PRETIUM RES INC | $15,291,000 | -3.6% | 1,651,328 | 0.0% | 0.92% | +1.1% | |
TEVA | TEVA PHARMACEUTICAL INDS LTDsponsored adr | $13,200,000 | -47.0% | 750,000 | 0.0% | 0.79% | -44.4% | |
IPXL | Sell | IMPAX LABORATORIES INC | $12,230,000 | -43.4% | 602,456 | -55.1% | 0.73% | -40.6% |
WVE | New | WAVE LIFE SCIENCES LTD | $6,327,000 | – | 290,885 | +100.0% | 0.38% | – |
MGP | Exit | MGM GROWTH PPTYS LLC | $0 | – | -500,000 | -100.0% | -0.83% | – |
REGN | Exit | REGENERON PHARMACEUTICALS | $0 | – | -51,505 | -100.0% | -1.44% | – |
ADNT | Exit | ADIENT PLC | $0 | – | -527,133 | -100.0% | -1.97% | – |
LH | Exit | LABORATORY CORP AMER HLDGS | $0 | – | -371,361 | -100.0% | -3.27% | – |
GILD | Exit | GILEAD SCIENCES INC | $0 | – | -921,797 | -100.0% | -3.72% | – |
SHPG | Exit | SHIRE PLCsponsored adr | $0 | – | -468,130 | -100.0% | -4.42% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2017-11-14
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
VERISIGN INC | 40 | Q1 2023 | 5.2% |
TEVA PHARMACEUTICAL INDS LTD | 40 | Q3 2023 | 7.3% |
MORGAN STANLEY | 35 | Q3 2023 | 11.8% |
ALNYLAM PHARMACEUTICALS INC | 34 | Q3 2021 | 4.9% |
POST HLDGS INC | 33 | Q4 2022 | 6.1% |
TG THERAPEUTICS INC | 33 | Q3 2021 | 3.8% |
CHARTER COMMUNICATIONS INC N | 30 | Q3 2023 | 7.2% |
ATARA BIOTHERAPEUTICS INC | 29 | Q4 2021 | 6.4% |
GODADDY INC | 28 | Q3 2023 | 8.9% |
CENTENE CORP DEL | 28 | Q3 2022 | 6.2% |
View BRIDGER MANAGEMENT, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
Surrozen, Inc./DESold out | February 14, 2022 | 0 | 0.0% |
Atara Biotherapeutics, Inc. | February 16, 2021 | 1,524,760 | 1.8% |
Dicerna Pharmaceuticals Inc | February 14, 2020 | 1,981,633 | 2.9% |
TG THERAPEUTICS, INC. | February 14, 2020 | 1,907,492 | 1.9% |
CHIMERIX INCSold out | February 14, 2017 | 0 | 0.0% |
PACIFIC BIOSCIENCES OF CALIFORNIA, INC.Sold out | February 14, 2017 | 0 | 0.0% |
SeaSpine Holdings CorpSold out | February 14, 2017 | 0 | 0.0% |
Trovagene, Inc.Sold out | February 14, 2017 | 0 | 0.0% |
ARROWHEAD RESEARCH CORPSold out | February 16, 2016 | 0 | 0.0% |
PENNYMAC FINANCIAL SERVICES, INC.Sold out | February 16, 2016 | 0 | 0.0% |
View BRIDGER MANAGEMENT, LLC's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
13F-HR/A | 2024-03-25 |
13F-HR/A | 2024-03-25 |
13F-HR/A | 2024-03-25 |
13F-HR/A | 2024-03-25 |
13F-HR/A | 2024-03-25 |
13F-HR/A | 2024-03-25 |
13F-HR/A | 2024-03-25 |
13F-HR | 2024-02-14 |
13F-HR | 2023-11-14 |
13F-HR | 2023-08-14 |
View BRIDGER MANAGEMENT, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.